Dangers of scientific bias against herbal drugs for coronavirus disease 2019

Yang, 2020, Use of herbal drugs to treat COVID-19 should be with caution, Lancet, 395, 1689, 10.1016/S0140-6736(20)31143-0 Yang, 2020, Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective, Int J Biol Sci, 16, 1708, 10.7150/ijbs.45538 Vanherweghem, 1993, Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs, Lancet, 341, 387, 10.1016/0140-6736(93)92984-2 IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. Pharmaceuticals. Lyon (FR): International Agency for Research on Cancer; 2012. Tamblyn, 1997, Unnecessary prescribing of NSAIDs and the management of NSAID-related gastropathy in medical practice, Ann Intern Med, 127, 429, 10.7326/0003-4819-127-6-199709150-00003 Panagioti, 2019, Prevalence, severity, and nature of preventable patient harm across medical care settings: systematic review and meta-analysis, BMJ, 366 National Institute on Drug Abuse. Overdose death rates. (2020-3-10) [2020-5-31]. https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates. European Medicines Agency. Herbal medicine products. [2020-5-31]. https://www.ema.europa.eu/en/human-regulatory/herbal-medicinal-products. World Health Organization. WHO global report on traditional and complementary medicine 2019. (2019) [2020-5-31]. https://apps.who.int/iris/handle/10665/312342. Ding, 2017, The Chinese prescription Lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function, BMC Complement Altern Med, 17, 130, 10.1186/s12906-017-1585-7 Li, 2020, Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2), Pharmacol Res, 156 Zheng, 2020, Tu Youyou winning the Nobel Prize: ethical research on the value and safety of traditional Chinese medicine, Bioethics, 34, 166, 10.1111/bioe.12456